Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alina Zaplatina"'
Autor:
Caroline Volz, Sara Breid, Carolin Selenz, Alina Zaplatina, Kristina Golfmann, Lydia Meder, Felix Dietlein, Sven Borchmann, Sampurna Chatterjee, Maike Siobal, Jakob Schöttle, Alexandra Florin, Mirjam Koker, Marieke Nill, Luka Ozretić, Niklas Uhlenbrock, Steven Smith, Reinhard Büttner, Hui Miao, Bingcheng Wang, H. Christian Reinhardt, Daniel Rauh, Michael Hallek, Amparo Acker-Palmer, Lukas C. Heukamp, Roland T. Ullrich
Publikováno v:
Cell Reports, Vol 31, Iss 4, Pp - (2020)
Summary: Anti-angiogenic treatment targeting vascular endothelial growth factor (VEGF)-VEGFR2 signaling has shown limited efficacy in lung cancer patients. Here, we demonstrate that inhibition of VEGFR2 in tumor cells, expressed in ∼20% of non-squa
Externí odkaz:
https://doaj.org/article/facb3169b7084c8eb4f67f107da06c75
Autor:
Luka Ozretić, Daniel Rauh, Lukas C. Heukamp, Roland T. Ullrich, Carolin Selenz, Sara Breid, Bingcheng Wang, Jakob Schöttle, H. Christian Reinhardt, Sampurna Chatterjee, Alexandra Florin, Mirjam Koker, Felix Dietlein, Reinhard Büttner, Michael Hallek, Steven Smith, Kristina Golfmann, Lydia Meder, Alina Zaplatina, Caroline Volz, Maike Siobal, Hui Miao, Amparo Acker-Palmer, Sven Borchmann, Niklas Uhlenbrock, Marieke Nill
Publikováno v:
Cell Rep
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Summary: Anti-angiogenic treatment targeting vascular endothelial growth factor (VEGF)-VEGFR2 signaling has shown limited efficacy in lung cancer patients. Here, we demonstrate that inhibition of VEGFR2 in tumor cells, expressed in ∼20% of non-squa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e41562252d214461eacecf75f9c462
https://hdl.handle.net/21.11116/0000-0008-0C46-D
https://hdl.handle.net/21.11116/0000-0008-0C46-D
